Sovran Advisors’s Boston Scientific BSX Stock Holding History

Sovran Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,073	Closed	-$208K	–	556
2025 Q3	$208K	Buy	+2,073	New	+$215K	0.02%	506

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Sovran Advisors's BSX Position: Q4 2025 in Review

Sovran Advisors sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 2,073 shares — an estimated $208K sold.

Sovran Advisors first reported a position in BSX in Q3 2025 and held it in 1 quarter. The position peaked at $208K in Q3 2025. 1,787 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

Sovran Advisors reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
Sovran Advisors sold 2,073 Boston Scientific shares in Q4 2025, an estimated $208K.
Sovran Advisors first reported a position in Boston Scientific in Q3 2025 and held it in 1 quarter.
Sovran Advisors's Boston Scientific position peaked at $208K in Q3 2025.
1,787 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Sovran Advisors's 13F filing for Q4 2025, filed 20 Jan 2026.